Suppr超能文献

长非编码 RNA 在癌症耐药中的作用。

The role of long non-coding RNAs in drug resistance of cancer.

机构信息

Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Xuzhou Infectious Disease Hospital, Xuzhou, China.

出版信息

Clin Genet. 2021 Jan;99(1):84-92. doi: 10.1111/cge.13800. Epub 2020 Aug 4.

Abstract

Long non-coding RNAs (lncRNAs), a class of long RNAs, are longer than 200 nucleotides in length but lack protein-coding capacity. LncRNAs, as critical genomic regulators, are involved in genomic imprinting regulation, histone modification and gene expression regulation as well as tumor initiation and progression. However, it is also found that lncRNAs are associated with drug resistance in several types of cancer. Drug resistance is an important reason for clinical chemotherapy failure, and the molecular mechanism of tumor resistance is complex, which is a process of multi-cause, multi-gene and multi-signal transduction pathway interaction. Then comprehending the mechanisms of chemoresistance will help find ways to control the tumor progression effectively. Therefore, in this review, we will construct lncRNAs /drug resistance interaction network and shed light on the role of lncRNAs in drug resistance.

摘要

长链非编码 RNA(lncRNAs)是一类长度大于 200 个核苷酸但缺乏蛋白编码能力的长 RNA。lncRNAs 作为关键的基因组调控因子,参与基因组印迹调控、组蛋白修饰和基因表达调控以及肿瘤的发生和发展。然而,也有研究发现 lncRNAs 与多种癌症的耐药性有关。耐药性是临床化疗失败的重要原因,肿瘤耐药的分子机制复杂,是一个多因素、多基因和多信号转导通路相互作用的过程。因此,了解耐药的机制有助于找到有效控制肿瘤进展的方法。因此,在本综述中,我们将构建 lncRNAs/药物耐药性相互作用网络,并探讨 lncRNAs 在耐药性中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验